Impaired LPS-induced signaling in microglia overexpressing the Wiskott-Aldrich syndrome protein N-terminal domain

International Immunology

Volumn 19, Issue 8, 2007, Pages 901-911

  Sato, Mitsuru ^a   Ogihara, Kazumasa ^a   Sawahata, Ryoko ^a   Sekikawa, Kenji ^a   Kitani, Hiroshi ^a  

^a NATIONAL INSTITUTE OF AGROBIOLOGICAL SCIENCES   (Japan)

Author keywords

LPS; Microglia; Signaling; Wiskott Aldrich syndrome protein

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; NITRIC OXIDE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASODILATOR STIMULATED PHOSPHOPROTEIN; VASODILATOR STIMULATED PHOSPHOPROTEIN 1; WISKOTT ALDRICH SYNDROME PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; C57BL 6 MOUSE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; GENE OVEREXPRESSION; IMMUNE RESPONSE; IMMUNOCYTOCHEMISTRY; IMMUNOMODULATION; IN VITRO STUDY; INNATE IMMUNITY; MICROGLIA; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; BRAIN; CELL LINE; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROGLIA; NF-KAPPA B; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; WISKOTT-ALDRICH SYNDROME PROTEIN;

EID: 34548553236     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxm074     Document Type: Article

References (48)

1. Ochs, H. D., Slichter, S. J., Harker, L. A., Von Behrens, W. E., Clark, R. A. and Wedgwood, R. J. 1980. The Wiskott-Aldrich syndrome: Studies of lymphocytes, granulocytes, and platelets. Blood 55:243.
2. Remold-O'Donnell, E., Rosen, F. S. and Kenney, D. M. 1996. Defects in Wiskott-Aldrich syndrome blood cells. Blood 87:2621.
3. Badolato, R., Sozzani, S., Malacarne, F. et al. 1998. Monocytes from Wiskott-Aldrich patients display reduced chemotaxis and lack of cell polarization in response to monocyte chemoattractant protein-1 and formyl-methionyl-leucyl-phenyl-alanine. J. Immunol. 161:1026.
4. Zicha, D., Allen, W. E., Brickell, P. M. et al. 1998. Chemotaxis of macrophages is abolished in the Wiskott-Aldrich syndrome. Br. J. Haematol. 101:659.
5. Lorenzi, R., Brickell, P. M., Katz, D. R., Kinnon, C. and Thrasher, A. J. 2000. Wiskott-Aldrich syndrome protein is necessary for efficient IgG-mediated phagocytosis. Blood 95:2943.
6. Snapper, S. B., Rosen, F. S., Mizoguchi, E. et al. 1998. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity 9:81.
7. Zhang, J., Shehabeldin, A., da Cruz, L. A. et al. 1999. Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes. J. Exp. Med. 190:1329.
8. Molina, I. J., Sancho, J., Terhorst, C., Rosen, F. S. and Remold-O'Donnell, E. 1993. T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses. J. Immunol. 151:4383.
9. Symons, M., Derry, J. M., Karlak, B. et al. 1996. Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell 84:723.
10. Rivero-Lezcano, O. M., Marcilla, A., Sameshima, J. H. and Robbins, K. C. 1995. Wiskott-Aldrich syndrome protein physically associates with Nck through Src homology 3 domains. Mol. Cell Biol. 15:5725.
11. She, H. Y., Rockow, S., Tang, J. et al. 1997. Wiskott-Aldrich syndrome protein is associated with the adapter protein Grb2 and the epidermal growth factor receptor in living cells. Mol. Biol. Cell. 8:1709.
12. Banin, S., Truong, O., Katz, D. R., Waterfield, M. D., Brickell, P. M. and Gout, I. 1996. Wiskott-Aldrich syndrome protein (WASp) is a binding partner for c-Src family protein-tyrosine kinases. Curr. Biol. 6:981.
13. Bunnell, S. C., Henry, P. A., Kolluri, R., Kirchhausen, T., Rickles, R. J. and Berg, L. J. 1996. Identification of Itk/Tsk Src homology 3 domain ligands. J. Biol. Chem. 271:25646.
14. Cory, G. O., MacCarthy-Morrogh, L., Banin, S. et al. 1996. Evidence that the Wiskott-Aldrich syndrome protein may be involved in lymphoid cell signaling pathways. J. Immunol. 157:3791.
15. Blanchoin, L., Amann, K. J., Higgs, H. N., Marchand, J. B., Kaiser, D. A. and Pollard, T. D. 2000. Direct observation of dendritic actin filament networks nucleated by Arp2/3 complex and WASP/Scar proteins. Nature 404:1007.
16. Sato, M., Tsuji, N. M., Gotoh, H. et al. 2001. Overexpression of the Wiskott-Aldrich syndrome protein N-terminal domain in transgenic mice inhibits T cell proliferative responses via TCR signaling without affecting cytoskeletal rearrangements. J. Immunol. 167:4701.
17. Sato, M., Iwaya, R., Ogihara, K. et al. 2005. Intrabodies against the EVH1 domain of Wiskott-Aldrich syndrome protein inhibit T cell receptor signaling in transgenic mice T cells. FEBS J. 272:6131.
18. Giulian, D. 1987. Ameboid microglia as effectors of inflammation in the central nervous system. J. Neurosci. Res. 18:155.
19. McGeer, P. L., Itagaki, S., Boyes, B. E. and McGeer, E. G. 1988. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38:1285.
20. Cras, P., Kawai, M., Siedlak, S. et al. 1990. Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease. Am. J. Pathol. 137:241.
21. McGeer, P. L., McGeer, E. G., Itagaki, S. and Mizukawa, K. 1987. Anatomy and pathology of the basal ganglia. Can. J. Neurol. Sci. 14:363.
22. Li, H., Cuzner, M. L. and Newcombe, J. 1996. Microglia-derived macrophages in early multiple sclerosis plaques. Neuropathol. Appl. Neurobiol. 22:207.
23. Price, R. W., Brew, B., Sidtis, J., Rosenblum, M., Scheck, A. C. and Cleary, P. 1988. The brain in AIDS: Central nervous system HIV-1 infection and AIDS dementia complex. Science 239:586.
24. Dickson, D. W., Mattiace, L. A., Kure, K., Hutchins, K., Lyman, W. D. and Brosnan, C. F. 1991. Microglia in human disease, with an emphasis on acquired immune deficiency syndrome. Lab. Invest. 64:135.
25. Sebire, G., Emilie, D., Wallon, C. et al. 1993. In vitro production of IL-6, IL-1 beta, and tumor necrosis factor-alpha by human embryonic microglial and neural cells. J. Immunol. 150:1517.
26. Lee, S. C., Liu, W., Dickson, D. W., Brosnan, C. F. and Berman, J. W. 1993. Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J. Immunol. 150:2659.
27. Chao, C. C., Hu, S., Molitor, T. W., Shaskan, E. G. and Peterson, P. K. 1992. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol. 149:2736.
28. Bhat, N. R., Zhang, P., Lee, J. C. and Hogan, E. L. 1998. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J. Neurosci. 18:1633.
29. Heyen, J. R., Ye, S., Finck, B. N. and Johnson, R. W. 2000. Interleukin (IL)-10 inhibits IL-6 production in microglia by preventing activation of NF-kappaB. Brain Res. Mol. Brain Res. 77:138.
30. Jeohn, G. H., Cooper, C. L., Jang, K. J. et al. 2002. Go6976 inhibits LPS-induced microglial TNFalpha release by suppressing p38 MAP kinase activation. Neuroscience 114:689.
31. Hanisch, U. K. 2002. Microglia as a source and target of cytokines. Glia 40:140.
32. Suzumura, A., Mezitis, S. G., Gonatas, N. K. and Silberberg, D. H. 1987. MHC antigen expression on bulk isolated macrophage-microglia from newborn mouse brain: Induction of Ia antigen expression by gamma-interferon. J. Neuroimmunol. 15:263.
33. 2+ influx and pore formation induced by the activation of P2X7 nucleotide receptors in mouse microglia cell line. Biochim. Biophys. Acta 1726:177.
34. Kitani, H., Shiurba, R., Sakakura, T. and Tomooka, Y. 1991. Isolation and characterization of mouse neural precursor cells in primary culture. In Vitro Cell. Dev. Biol. 27A:615.
35. Hashimoto, A., Onodera, T., Ikeda, H. and Kitani, H. 2000. Isolation and characterisation of fetal bovine brain cells in primary culture. Res. Vet. Sci. 69:39.
36. Ohsawa, K., Imai, Y., Nakajima, K. and Kohsaka, S. 1997. Generation and characterization of a microglial cell line, MG5, derived from a p53-deficient mouse. Glia 21:285.
37. Akira, S., Takeda, K. and Kaisho, T. 2001. Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat. Immunol. 2:675.
38. Karin, M. and Ben-Neriah, Y. 2000. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18:621.
39. Sizemore, N., Leung, S. and Stark, G. R. 1999. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-κB p65/RelA subunit. Mol. Cell Biol. 19:4798.
40. Buss, H., Dorrie, A., Schmitz, M. L., Hoffmann, E., Resch, K. and Kracht, M. 2004. Constitutive and interleukin-1-inducible phosphorylation of p65 NF-κB at serine 536 is mediated by multiple protein kinases including IκB kinase (IKK)-α, IKKβ, IKKε, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription. J. Biol. Chem. 279:55633.
41. Huang, W., Ochs, H. D., Dupont, B. and Vyas, Y. M. 2005. The Wiskott-Aldrich syndrome protein regulates nuclear translocation of NFAT2 and NF-κB (ReIA) independently of its role in filamentous actin polymerization and actin cytoskeletal rearrangement. J. Immunol. 174:2602.
42. Jefferies, C. A., Doyle, S., Brunner, C. et al. 2003. Bruton's Tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor κB activation by Toll-like receptor 4. J. Biol. Chem. 278:26258.
43. Sawada, M., Suzumura, A., Hosoya, H., Marunouchi, T. and Nagatsu, T. 1999. Interleukin-10 inhibits both production of cytokines and expression of cytokine receptors in microglia. J. Neurochem. 72:1466.
44. Ehrlich, L. C., Hu, S., Peterson, P. K. and Chao, C. C. 1998. IL-10 down-regulates human microglial IL-8 by inhibition of NF-κB activation. Neuroreport 9:1723.
45. Heyen, J. R., Ye, S., Finck, B. N. and Johnson, R. W. 2000. Interleukin (IL)-10 inhibits IL-6 production in microglia by preventing activation of NF-κB. Brain Res. Mol. Brain Res. 77:138.
46. Bal-Price, A. and Brown, G. C. 2001. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J. Neurosci. 21:6480.
47. Mizuno, T., Kurotani, T., Komatsu, Y. et al. 2004. Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia. Neuropharmacology 46:404.
48. Parry, G. C. and Mackman, N. 1997. Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription. J. Immunol. 159:5450.